Nanovi A/S

Danish medical device company specialized in precision marking for better cancer therapy. Our dedication is to empower healthcare professionals with the best possible tools for the delivery of high precision radiation therapy and surgery to benefit cancer patients and to support efficiency in healthcare. Nanovi has a portfolio of unique in-house developed liquid fiducial markers for both human and veterinary use. Our markers enhance target visibility on medical imaging and enable high precision radiation therapy, including proton therapy, and surgery. BioXmark® is a liquid fiducial marker for high precision IGRT and our lead product for human use. The marker can be injected both percutaneously and endoscopically via thin needles. After injection, BioXmark® changes viscosity to form a highly viscous marker with high positional stability, The markers are visible on all image modalities used in the IGRT planning and treatment phases including X-ray (kV, CT, CBCT, Flouroscopy) MRI and US. PetXmark™ is a liquid fiducial marker for use to radiographically mark subcutaneous tissue in dogs and cats and our first veterinary product. PetXmark™ has been evaluated in a clinical trial for use to guide radiotherapy of skin and subcutaneous tumors and is commercialized in the US. Nanovi's products are derived from a patented biomaterial marker technology, co-invented with the Department of Health Technology at the Technical University of Denmark, DTU. #medicaldevices #bioXmark #nanovi

• Employees1
• Founded2012